The genetic requirements for fast and slow growth in mycobacteria
- PMID: 19479006
- PMCID: PMC2685279
- DOI: 10.1371/journal.pone.0005349
The genetic requirements for fast and slow growth in mycobacteria
Abstract
Mycobacterium tuberculosis infects a third of the world's population. Primary tuberculosis involving active fast bacterial replication is often followed by asymptomatic latent tuberculosis, which is characterised by slow or non-replicating bacteria. Reactivation of the latent infection involving a switch back to active bacterial replication can lead to post-primary transmissible tuberculosis. Mycobacterial mechanisms involved in slow growth or switching growth rate provide rational targets for the development of new drugs against persistent mycobacterial infection. Using chemostat culture to control growth rate, we screened a transposon mutant library by Transposon site hybridization (TraSH) selection to define the genetic requirements for slow and fast growth of Mycobacterium bovis (BCG) and for the requirements of switching growth rate. We identified 84 genes that are exclusively required for slow growth (69 hours doubling time) and 256 genes required for switching from slow to fast growth. To validate these findings we performed experiments using individual M. tuberculosis and M. bovis BCG knock out mutants. We have demonstrated that growth rate control is a carefully orchestrated process which requires a distinct set of genes encoding several virulence determinants, gene regulators, and metabolic enzymes. The mce1 locus appears to be a component of the switch to slow growth rate, which is consistent with the proposed role in virulence of M. tuberculosis. These results suggest novel perspectives for unravelling the mechanisms involved in the switch between acute and persistent TB infections and provide a means to study aspects of this important phenomenon in vitro.
Conflict of interest statement
Figures





Similar articles
-
The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.Front Cell Infect Microbiol. 2017 Jun 8;7:239. doi: 10.3389/fcimb.2017.00239. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28642843 Free PMC article.
-
Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.Science. 1998 Oct 23;282(5389):759-62. doi: 10.1126/science.282.5389.759. Science. 1998. PMID: 9784137
-
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.Infect Immun. 1996 Jan;64(1):16-22. doi: 10.1128/iai.64.1.16-22.1996. Infect Immun. 1996. PMID: 8557334 Free PMC article.
-
Genomics of Mycobacterium bovis.Tuberculosis (Edinb). 2001;81(1-2):157-63. doi: 10.1054/tube.2000.0269. Tuberculosis (Edinb). 2001. PMID: 11463237 Review.
-
To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?Curr Opin Microbiol. 2010 Feb;13(1):86-92. doi: 10.1016/j.mib.2009.11.006. Epub 2009 Dec 23. Curr Opin Microbiol. 2010. PMID: 20036184 Free PMC article. Review.
Cited by
-
Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture.J R Soc Interface. 2016 Nov;13(124):20160745. doi: 10.1098/rsif.2016.0745. J R Soc Interface. 2016. PMID: 27807274 Free PMC article.
-
A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis.Gut Pathog. 2009 Dec 23;1:25. doi: 10.1186/1757-4749-1-25. Gut Pathog. 2009. PMID: 20030828 Free PMC article.
-
Modulatory Impact of the sRNA Mcr11 in Two Clinical Isolates of Mycobacterium tuberculosis.Curr Microbiol. 2022 Jan 4;79(2):39. doi: 10.1007/s00284-021-02733-0. Curr Microbiol. 2022. PMID: 34982251
-
Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.PLoS One. 2015 Sep 18;10(9):e0138253. doi: 10.1371/journal.pone.0138253. eCollection 2015. PLoS One. 2015. PMID: 26382066 Free PMC article.
-
Interplay between gene expression noise and regulatory network architecture.Trends Genet. 2012 May;28(5):221-32. doi: 10.1016/j.tig.2012.01.006. Epub 2012 Feb 25. Trends Genet. 2012. PMID: 22365642 Free PMC article. Review.
References
-
- World Health Organisation. Tuberculosis Fact Sheet 2008
-
- Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Micro. 2003;1:97–105. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases